Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2021 | 2 |
2022 | 2 |
2023 | 2 |
2024 | 1 |
Search Results
7 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Optimization and evaluation of a live virus SARS-CoV-2 neutralization assay.
PLoS One. 2022 Jul 28;17(7):e0272298. doi: 10.1371/journal.pone.0272298. eCollection 2022.
PLoS One. 2022.
PMID: 35901110
Free PMC article.
Preclinical evaluation of a candidate naked plasmid DNA vaccine against SARS-CoV-2.
Lassaunière R, Polacek C, Gram GJ, Frische A, Tingstedt JL, Krüger M, Dorner BG, Cook A, Brown R, Orekov T, Putmon-Taylor T, Campbell TA, Greenhouse J, Pessaint L, Andersen H, Lewis MG, Fomsgaard A.
Lassaunière R, et al. Among authors: frische a.
NPJ Vaccines. 2021 Dec 20;6(1):156. doi: 10.1038/s41541-021-00419-z.
NPJ Vaccines. 2021.
PMID: 34930909
Free PMC article.
Item in Clipboard
A Candidate DNA Vaccine Encoding the Native SARS-CoV-2 Spike Protein Induces Anti-Subdomain 1 Antibodies.
Frische A, Gunalan V, Krogfelt KA, Fomsgaard A, Lassaunière R.
Frische A, et al.
Vaccines (Basel). 2023 Sep 3;11(9):1451. doi: 10.3390/vaccines11091451.
Vaccines (Basel). 2023.
PMID: 37766128
Free PMC article.
Item in Clipboard
Antigen-Heterologous Vaccination Regimen Triggers Alternate Antibody Targeting in SARS-CoV-2-DNA-Vaccinated Mice.
Frische A, Krogfelt KA, Fomsgaard A, Lassaunière R.
Frische A, et al.
Vaccines (Basel). 2024 Feb 20;12(3):218. doi: 10.3390/vaccines12030218.
Vaccines (Basel). 2024.
PMID: 38543852
Free PMC article.
Item in Clipboard
Neutralizing Antibodies Against the SARS-CoV-2 Omicron Variant (BA.1) 1 to 18 Weeks After the Second and Third Doses of the BNT162b2 mRNA Vaccine.
Lassaunière R, Polacek C, Frische A, Boding L, Sækmose SG, Rasmussen M, Fomsgaard A.
Lassaunière R, et al. Among authors: frische a.
JAMA Netw Open. 2022 May 2;5(5):e2212073. doi: 10.1001/jamanetworkopen.2022.12073.
JAMA Netw Open. 2022.
PMID: 35560054
Free PMC article.
Item in Clipboard
High titers of neutralizing SARS-CoV-2 antibodies six months after symptom onset are associated with increased severity in COVID-19 hospitalized patients.
Sejdic A, Frische A, Jørgensen CS, Rasmussen LD, Trebbien R, Dungu A, Holler JG, Ostrowski SR, Eriksson R, Søborg C, Nielsen TL, Fischer TK, Lindegaard B, Franck KT, Harboe ZB.
Sejdic A, et al. Among authors: frische a.
Virol J. 2023 Jan 25;20(1):14. doi: 10.1186/s12985-023-01974-8.
Virol J. 2023.
PMID: 36698135
Free PMC article.
Item in Clipboard
In vitro Characterization of Fitness and Convalescent Antibody Neutralization of SARS-CoV-2 Cluster 5 Variant Emerging in Mink at Danish Farms.
Lassaunière R, Fonager J, Rasmussen M, Frische A, Polacek C, Rasmussen TB, Lohse L, Belsham GJ, Underwood A, Winckelmann AA, Bollerup S, Bukh J, Weis N, Sækmose SG, Aagaard B, Alfaro-Núñez A, Mølbak K, Bøtner A, Fomsgaard A.
Lassaunière R, et al. Among authors: frische a.
Front Microbiol. 2021 Jun 25;12:698944. doi: 10.3389/fmicb.2021.698944. eCollection 2021.
Front Microbiol. 2021.
PMID: 34248922
Free PMC article.
Item in Clipboard
Cite
Cite